Suppr超能文献

氟达拉滨加泼尼松治疗后的迟发性李斯特菌病

Late listeriosis after fludarabine plus prednisone treatment.

作者信息

Girmenia C, Mauro F R, Rahimi S

机构信息

Department of Human Biopathology, University La Sapienza, Rome, Italy.

出版信息

Br J Haematol. 1994 Jun;87(2):407-8. doi: 10.1111/j.1365-2141.1994.tb04932.x.

Abstract

Fludarabine plus prednisome treatment in patients with chronic lymphocytic leukaemia has recently been correlated with an increased incidence of Listeria monocytogenes infections. We observed a patient with chronic lymphocytic leukaemia who received fludarabine plus prednisone and developed a fatal listeriosis 7 months later. A further case of listeriosis has recently been described in a man who developed the infection 2 years after successful fludarabine treatment while he had a normal CD4 lymphocyte count. These cases suggest that the risk period for the development of such an unusual infection could be unexpectedly and unpredictably long. This data could be important in the evaluation of a possible antibacterial prophylaxis schedule and in the wariness about the potential danger of food known to contain L. monocytogenes.

摘要

氟达拉滨联合泼尼松治疗慢性淋巴细胞白血病患者,最近被发现与单核细胞增生李斯特菌感染发生率增加相关。我们观察到一名慢性淋巴细胞白血病患者接受氟达拉滨联合泼尼松治疗,7个月后发生致命性李斯特菌病。最近还报道了另一例李斯特菌病病例,一名男性在成功接受氟达拉滨治疗2年后发生感染,当时他的CD4淋巴细胞计数正常。这些病例表明,发生这种不寻常感染的风险期可能出乎意料地长且不可预测。该数据在评估可能的抗菌预防方案以及警惕已知含有单核细胞增生李斯特菌的食物的潜在危险方面可能具有重要意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验